Eris Lifesciences Limited (NSE:ERIS) — Market Cap & Net Worth

$1.98 Billion USD · Rs183.11 Billion INR · Rank #6254

Market Cap & Net Worth: Eris Lifesciences Limited (ERIS)

Eris Lifesciences Limited (NSE:ERIS) has a market capitalization of $1.98 Billion (Rs183.11 Billion) as of September 19, 2026. Listed on the NSE stock exchange, this India-based company holds position #6254 globally and #282 in its home market, demonstrating a -1.03% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Eris Lifesciences Limited's stock price Rs1321.30 by its total outstanding shares 138583305 (138.58 Million). Also see Eris Lifesciences Limited total assets for a full breakdown of the balance sheet.

Eris Lifesciences Limited Market Cap History: 2017 to 2026

Eris Lifesciences Limited's market capitalization history from 2017 to 2026. Data shows growth from $1.15 Billion to $1.98 Billion (9.33% CAGR). Also see cash flow conversion of Eris Lifesciences Limited for how efficiently the company converts equity into cash flow.

Index Memberships

Eris Lifesciences Limited is a constituent of 4 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
NIFTY 500 NIFTY500	$3.08 Trillion	0.06%	#250 of 500
NIFTY MIDSMALLCAP 400 NIFTYMIDSML400	$1.15 Trillion	0.17%	#162 of 400
NIFTY TOTAL MARKET NIFTYTOTALMKT	$3.18 Trillion	0.06%	#245 of 750
NIFTY SMALLCAP 250 NISM250	$411.67 Billion	0.48%	#69 of 250

Weight: Eris Lifesciences Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Eris Lifesciences Limited Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Eris Lifesciences Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check ERIS live share price for real-time trading data and today's change.

Latest Price to Sales (P/S) Ratio

0.06x

Eris Lifesciences Limited's market cap is 0.06 times its annual revenue

Industry average: 0.57x Lower than industry average

Latest Price to Earnings (P/E) Ratio

0.32x

Eris Lifesciences Limited's market cap is 0.32 times its annual earnings

Industry average: 2.01x Lower than industry average

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2017	$1.15 Billion	$7.49 Billion	$2.47 Billion	0.15x	0.47x
2018	$993.57 Million	$8.27 Billion	$2.94 Billion	0.12x	0.34x
2019	$685.37 Million	$9.67 Billion	$2.91 Billion	0.07x	0.24x
2020	$853.18 Million	$10.58 Billion	$2.96 Billion	0.08x	0.29x
2021	$1.13 Billion	$11.93 Billion	$3.55 Billion	0.09x	0.32x
2022	$970.05 Million	$13.26 Billion	$4.06 Billion	0.07x	0.24x
2023	$1.36 Billion	$16.62 Billion	$3.82 Billion	0.08x	0.36x
2024	$2.06 Billion	$19.91 Billion	$3.92 Billion	0.10x	0.53x
2025	$2.26 Billion	$28.79 Billion	$3.52 Billion	0.08x	0.64x
2026	$1.98 Billion	$31.29 Billion	$6.20 Billion	0.06x	0.32x

Competitor Companies of ERIS by Market Capitalization

Companies near Eris Lifesciences Limited in the global market cap rankings as of September 19, 2026. Review ERIS tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.

Key companies related to Eris Lifesciences Limited by market ranking:

Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
GALDERMA GROUP AG (NYSE:GALDY): Ranked #613 globally with a market cap of $44.92 Billion USD.
Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #635 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #670 globally with a market cap of $40.99 Billion USD ( CN¥280.10 Billion CNY).

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#518	Takeda Pharmaceutical Co Ltd ADR	NYSE:TAK	$52.60 Billion	$16.65
#613	GALDERMA GROUP AG	NYSE:GALDY	$44.92 Billion	$38.53
#635	Takeda Pharmaceutical Company Limited	F:TKDA	$43.60 Billion	€16.90
#670	Jiangsu Hengrui Medicine Co Ltd	SHG:600276	$40.99 Billion	CN¥43.91

Eris Lifesciences Limited Historical Marketcap From 2017 to 2026

Between 2017 and today, Eris Lifesciences Limited's market cap moved from $1.15 Billion to $ 1.98 Billion, with a yearly change of 9.33%.

Year	Market Cap	Change (%)
2026	Rs1.98 Billion	-12.24%
2025	Rs2.26 Billion	+9.60%
2024	Rs2.06 Billion	+50.96%
2023	Rs1.36 Billion	+40.59%
2022	Rs970.05 Million	-13.93%
2021	Rs1.13 Billion	+32.10%
2020	Rs853.18 Million	+24.48%
2019	Rs685.37 Million	-31.02%
2018	Rs993.57 Million	-13.50%
2017	Rs1.15 Billion	--

End of Day Market Cap According to Different Sources

On Sep 19th, 2026 the market cap of Eris Lifesciences Limited was reported to be:

Source	Market Cap
Yahoo Finance	$1.98 Billion USD
MoneyControl	$1.98 Billion USD
MarketWatch	$1.98 Billion USD
marketcap.company	$1.98 Billion USD
Reuters	$1.98 Billion USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Eris Lifesciences Limited

NSE:ERIS India Drug Manufacturers - Specialty & Generic

Market Cap

$1.98 Billion

Rs183.11 Billion INR

Market Cap Rank

#6254 Global

#282 in India

Share Price

Rs1321.30

Change (1 day)

+0.81%

52-Week Range

Rs1271.00 - Rs1701.30

All Time High

Rs1847.70